CRISPR Inventor Condemns Chinese Gene-Editing Experiment
A Chinese-led experiment to create gene-edited babies was “completely unnecessary and irresponsible,” an international DNA-editing pioneer has told Caixin.
Chinese-American biologist Feng Zhang, who was on the team that invented the gene-editing technology CRISPR, condemned the work of Chinese scientist He Jiankui, who on Monday announced the births of the world’s first gene-edited babies in China. He claimed to have removed a gene from the embryos of twin girls to make them resistant to HIV, which he said might have otherwise been passed on to them by their HIV-positive father.
“First of all, there wasn’t a good justification for applying gene editing in this particular case,” Zhang told Caixin at the International Gene Editing Summit in Hong Kong.
“Second of all, I was concerned by the lack of transparency,” he added. “It seems that the school didn’t even know about these experiments.”
Zhang said that exposing the embryos to the unknown risks of gene editing was uncalled for. “There is a standard protocol for treating the mother who is not HIV-positive,” he said. “Given that you already have an established and safe procedure, to expose the child to this level of risk is completely unnecessary and irresponsible.”
Zhang also pointed out that the procedure may not be completely reliable and that many factors could affect the efficacy and accuracy of gene-editing.
“Fundamentally, I don’t think genome editing is ready to be applied in embryos for implantation purposes. There are still technical hurdles we have to solve,” he said.
When asked about the effect of the edited genes on future generations, Zhang simply said, “I don’t know.”
On Nov. 26, Zhang issued a statement calling for a moratorium on implanting edited embryos in human wombs until comprehensive safety measures are introduced.
Contact reporter Ren Qiuyu (firstname.lastname@example.org)
May 05 06:52 PM
May 05 06:46 PM
May 05 06:43 PM
May 04 06:37 PM
May 04 06:34 PM
May 04 05:50 PM
Apr 30 07:05 PM
Apr 30 06:31 PM
Apr 30 06:27 PM
Apr 29 07:43 PM
Apr 29 07:19 PM
Apr 29 07:05 PM
- 1In Depth: No More Regulatory Blind Eye for Internet M&A
- 2Sinopharm’s Vaccine Nears Emergency-Use Approval by WHO
- 3China Manufacturing Expansion Picks Up Speed, Caixin PMI Shows
- 4Morgan Stanley Set to Take Greater Control Over Two China Joint Ventures
- 5China Policy Banks Test New Bond Issuance Program, Spelling Bad News for Middlemen
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas